Stock STAB STATERA BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Statera Biopharma, Inc. Nasdaq

Equities

STAB

US8575611046

Delayed Nasdaq
Other stock markets
 11:37:36 2024-04-29 am EDT 		5-day change 1st Jan Change
0.0007 USD 0.00% Intraday chart for Statera Biopharma, Inc. 0.00% -99.98%
2023 Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. CI
2023 Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Statera Biopharma, Inc. Announces Board Changes
CI
Statera Biopharma, Inc. Announces Executive Changes
CI
Statera Biopharma's CFO Peter Aronstam Resigns
MT
Statera Biopharma, Inc. Announces Resignation of Peter Aronstam as Chief Financial Officer
CI
Statera Biopharma, Inc. Appoints Christopher Zosh as Interim Principal Financial Officer and Principal Accounting Officer
CI
Statera Biopharma, Inc. Resignation Cozette M. McAvoy, Chief Legal Officer
CI
Statera Biopharma Announces Changes to Board of Directors
CI
Cytocom, Inc. will Change its Name to Statera BioPharma, Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. STAB Stock
  4. STAB Stock
  5. News Statera Biopharma, Inc.
  6. Insiders